$1.15
4.55%
Nasdaq, Jun 28, 10:00 pm CET
ISIN
US6085501095
Symbol
MTEM
Sector
Industry

Molecular Templates, Inc. Target price 2024 - Analyst rating & recommendation

Molecular Templates, Inc. Classifications & Recommendation:

Buy
100%

Molecular Templates, Inc. Target price

Target price $18.00
Course $1.15
Price potential
Number of estimates 1
1 Analyst has issued a Molecular Templates, Inc. price target 2025. The average Molecular Templates, Inc. target price is $18.00. This is higher than the current share price.
A rating was issued by 1 analysts: 1 Analysts recommend Molecular Templates, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the Molecular Templates, Inc. share has an average upside potential 2025 of . Most analysts recommend the Molecular Templates, Inc. share at Purchase.

Sales and margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 57.31 12.19
190.18% 78.73%
Net margin -16.87% -151.09%
97.49% 795.82%

1 Analyst has issued a sales forecast Molecular Templates, Inc. 2024 . The average Molecular Templates, Inc. sales estimate is

$12.2m
unlock
. This is
61.62% lower
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$12.2m 61.62%
unlock
, the lowest is
$12.2m 61.62%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $57.3m 190.18%
2024
$12.2m 78.73%
unlock
2025
$1.2m 90.52%
unlock

1 Analyst has issued a net profit forecast Molecular Templates, Inc. 2024 . The average Molecular Templates, Inc. net profit estimate is

$-18.4m
unlock
. This is
21.33% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-18.4m 21.33%
unlock
, the lowest is
$-18.4m 21.33%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-9.7m 92.71%
2024
$-18.4m 90.56%
unlock
2025
$-20.5m 11.35%
unlock

Net margin

2023 -16.87% 97.49%
2024
-151.09% 795.82%
unlock
2025
-1,774.52% 1,074.48%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -1.80 -3.43
92.71% 90.56%
P/E ratio negative
EV/Sales 1.02

1 Analysts have issued a Molecular Templates, Inc. forecast for earnings per share. The average Molecular Templates, Inc. <a href=/blog/eps>EPS is

$-3.43
unlock
. This is
21.33% higher
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$-3.43 21.33%
unlock
, the lowest is
$-3.43 21.33%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-1.80 92.71%
2024
$-3.43 90.56%
unlock
2025
$-3.82 11.37%
unlock

P/E ratio

Current -0.26 51.85%
2024
-0.34 30.77%
unlock
2025
-0.30 11.76%
unlock

Based on analysts' sales estimates for 2024, the Molecular Templates, Inc. share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 0.39 45.07%
2024
1.02 161.44%
unlock
2025
10.75 954.59%
unlock

P/S ratio

Current 0.24 55.16%
2024
0.62 160.44%
unlock
2025
6.55 954.66%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now